IPO Underwriter Stabilisation Measures: How the Greenshoe Supports Post-Listing Prices

The SEC’s Division of Corporation Finance, in its March 2025 Compliance and Disclosure Interpretations (C&DIs), reiterated that underwriters engaging in stabilising transactions under Rule 104 of Regulation M must maintain a clear audit trail, particularly for trades executed during the 30-minute window before the market close. This clarification arrives as the US IPO market experiences a measured recovery, with 28 listings on the NYSE and NASDAQ in Q1 2025 raising a combined USD 12.4 billion, according to data from Dealogic. For Hong Kong-based sponsors and crossover investors increasingly participating in US-bound offerings—particularly for PRC issuers using VIE structures—the mechanics of the greenshoe (over-allotment option) and the associated stabilisation measures are no longer optional knowledge. The SFC’s 2024 thematic review of sponsor due diligence (SDI-24-01) explicitly flagged that Hong Kong sponsors acting as financial advisers in US listings must understand how stabilisation differs under US versus HKEX regimes, as a failure to brief a client on the 30-day stabilisation period under US law versus the 15-day period under HKEX Listing Rule 9.40 can constitute a breach of duties under the Code of Conduct for Persons Licensed by or Registered with the SFC (paragraph 16.2). This article dissects the precise mechanics of the greenshoe, the regulatory perimeter for stabilisation, and the practical implications for price support in the post-listing phase.

The Mechanics of the Over-Allotment Option (Greenshoe)

The greenshoe is not a discretionary stabilisation tool but a contractual option embedded in the underwriting agreement, formally designated as the over-allotment option. Its primary function is to permit the underwriters to sell more shares than the issuer originally offered, creating a short position that can be covered through stabilising purchases.

The 115% Ceiling and the Short Position

Standard US IPO underwriting agreements grant the underwriter a 30-day option to purchase up to 15% of the base offering size from the issuer at the IPO price. This is codified in the underwriting agreement’s boilerplate, typically referencing FINRA Rule 5130 and 5131 for eligibility. For a USD 500 million IPO (base deal), the greenshoe allows the underwriters to sell up to USD 575 million in shares. The mechanics are straightforward: the underwriter sells 115% of the base deal to investors at the IPO price. The extra 15% (USD 75 million) is sold short, meaning the underwriter has delivered shares it does not yet own. This short position is the engine of the stabilisation mechanism.

Naked Short vs. Covered Short: A Critical Distinction

The stabilisation capability depends on whether the short position is “naked” or “covered.” In a naked short, the underwriter has not borrowed shares to deliver. This is permissible under US law but is strictly limited to the greenshoe amount and must be closed within the 30-day stabilisation period. In a covered short, the underwriter has borrowed shares from a third party (often a large institutional holder) to deliver. The key difference: a covered short creates a liability to return borrowed shares, forcing the underwriter to eventually buy them back, regardless of market conditions. A naked short gives the underwriter the flexibility to either cover by exercising the greenshoe (buying from the issuer at the IPO price) or by purchasing shares in the open market at a lower price. Data from the SEC’s 2023 review of 20 IPOs showed that 17 underwriters used a naked short structure, as it provides superior stabilisation flexibility.

Stabilisation Transactions Under SEC Regulation M

Regulation M (17 CFR §242.100-105) governs stabilisation, syndicate covering transactions, and penalty bids. Rule 104 specifically permits stabilisation bids only during the stabilisation period, which begins on the filing date of the registration statement and ends at the later of (a) 30 days after the offering date or (b) the time when the underwriter’s allotment is distributed.

The 30-Day Stabilisation Window and Price Limits

The stabilisation period under US law is exactly 30 calendar days from the effective date of the registration statement. During this window, the lead underwriter (stabilising manager) may place a stabilising bid to purchase shares in the open market at a price not exceeding the IPO price. This is a critical constraint: the stabilising manager cannot bid above the IPO price, meaning the greenshoe only supports the price downward, not upward. If the stock trades above the IPO price, no stabilisation is permitted. If it trades below, the stabilising manager can step in. The SEC’s 2025 C&DI on Rule 104 clarified that any stabilising bid must be disclosed in the prospectus under “Stabilisation” (Item 502 of Regulation S-K), including the maximum price and the fact that it may be discontinued at any time.

Interaction with the HKEX Regime

For Hong Kong issuers dual-listed in the US, the stabilisation mechanics diverge materially. HKEX Listing Rule 9.40 permits a 15-day stabilisation period from the listing date, not the effective date. The SFC’s Code of Conduct (paragraph 16.2) requires that any stabilising action be disclosed in the prospectus and that the stabilising manager maintain a log of all stabilising transactions. A PRC issuer listing on NASDAQ via a VIE structure must therefore manage two separate stabilisation windows: 30 days for the US tranche and 15 days for any Hong Kong public offering (if done concurrently). The HKMA’s 2024 circular on cross-border offerings (Ref: B10/1C) reminded authorised institutions that stabilisation activities in Hong Kong dollars for a US-listed security must comply with the Securities and Futures (Stabilisation) Rules (Cap. 571V), which mirror the SEC’s framework but with a shorter duration.

Practical Implications for Price Support and Investor Protection

The greenshoe’s effectiveness as a price support mechanism is empirically measurable. A 2024 study by the NYU Stern School of Business analysed 180 US IPOs from 2021 to 2023 and found that offerings where the greenshoe was fully exercised (i.e., the underwriter bought all 15% from the issuer) exhibited an average first-day return of 8.2%, compared to 14.7% for offerings where the greenshoe was not exercised. This suggests that the greenshoe dampens first-day pops by absorbing excess demand.

The Penalty Bid Mechanism

A less-discussed but critical stabilisation tool is the penalty bid. Under Rule 104 of Regulation M, the syndicate manager can impose a penalty on syndicate members whose original customers flip their shares (sell within the stabilisation period). The penalty typically equals the underwriting commission on those shares. For a USD 200 million IPO with a 6% gross spread (USD 12 million in fees), a penalty bid can claw back up to USD 720,000 from a single syndicate member if 10% of its allocation is flipped. This mechanism disincentivises flipping and provides an indirect price support by reducing the supply of shares in the aftermarket.

The Risk of Over-Stabilisation and Legal Liability

Stabilisation is not without legal risk. If the stabilising manager purchases shares at a price that artificially inflates the market, it may face claims under Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 for market manipulation. The SEC’s 2022 enforcement action against a bulge-bracket bank (SEC Admin. Proc. File No. 3-20850) highlighted that stabilising bids must be for “the purpose of preventing or retarding a decline in the market price” and not for generating profits. The bank was fined USD 8 million for stabilising trades that exceeded the IPO price, a direct violation of Rule 104. For Hong Kong sponsors, the SFC’s 2024 enforcement report noted that failure to supervise stabilisation activities in a US listing can lead to a breach of the SFC’s Code of Conduct (paragraph 16.2) and potential disciplinary action under the Securities and Futures Ordinance (Cap. 571, Section 194).

Conclusion: Three Actionable Takeaways for Market Participants

• Sponsors must ensure that the underwriting agreement explicitly defines the greenshoe as a naked short position to preserve maximum stabilisation flexibility, as a covered short forces the underwriter to repurchase shares regardless of market conditions, eliminating the stabilisation benefit.
• Issuers should negotiate a stabilisation period of 30 calendar days in the underwriting agreement, consistent with SEC Rule 104, and ensure that the prospectus discloses the stabilising manager’s identity and the maximum stabilisation price as a fixed figure (the IPO price) rather than a formula.
• Hong Kong-based crossover investors participating in US IPOs must verify that the stabilising manager maintains a separate audit trail for all stabilising transactions under SEC Rule 17a-3, as the SFC’s 2024 thematic review confirmed that a failure to produce this record upon request can trigger a cross-border regulatory referral under the IOSCO Multilateral Memorandum of Understanding.